The Influence of Race and Common Genetic Variations on Outcomes After Pediatric Heart Transplantation

D J Green1, M M Brooks2, G J Burckart1

  • 1Pediatric Clinical Pharmacology Staff, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.

Insights

Racial disparities persist in pediatric heart transplantation outcomes. Black children faced higher risks of death, graft loss, and rejection, even after accounting for clinical and genetic factors.

Area of Science:

  • Pediatric Cardiology
  • Transplantation Medicine
  • Health Disparities Research

Background:

  • Significant racial disparities exist in pediatric heart transplantation outcomes.
  • Unfavorable outcomes, including death and graft loss, disproportionately affect Black children.

Purpose of the Study:

  • To identify specific pediatric post-heart transplantation outcomes that differ by race.
  • To investigate whether demographic, clinical, and genetic factors explain these racial differences.

Main Methods:

  • Retrospective analysis of 80 Black and 450 non-Black pediatric heart transplant recipients (1993-2008).
  • Genotyping for 20 candidate genes.
  • Multivariate regression analysis adjusting for multiple variables.

Main Results:

  • Black recipients had significantly higher unadjusted 5-year rates of death, graft loss, acute rejection with hemodynamic compromise, and late rejection.
  • Black recipients were older at transplant, more likely to have cardiomyopathy and public insurance, and less likely to receive induction therapy.
  • Even after adjusting for clinical and genetic factors, Black race remained a significant risk factor for adverse outcomes, explaining only 8-19% of the excess risk.

Conclusions:

  • Racial differences in survival, graft loss, and rejection outcomes after pediatric heart transplantation are confirmed.
  • These disparities are not fully explained by known recipient demographic, clinical, or genetic attributes.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
81
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
69
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
624
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
1.5K